{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T11:43:55Z","timestamp":1776512635443,"version":"3.51.2"},"reference-count":33,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.ejso.2025.110536","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:06:47Z","timestamp":1761077207000},"page":"110536","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Controlling perfusion temperature relates to better outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy"],"prefix":"10.1016","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-9172","authenticated-orcid":false,"given":"Felipe","family":"Lopez-Ramirez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-8341-8558","authenticated-orcid":false,"given":"Kseniia","family":"Uzhegova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-3827","authenticated-orcid":false,"given":"Mary Caitlin","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5065-1416","authenticated-orcid":false,"given":"Luis Felipe","family":"Falla-Zuniga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4772-5477","authenticated-orcid":false,"given":"Andrei","family":"Nikiforchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9704-6547","authenticated-orcid":false,"given":"Ekaterina","family":"Baron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Nieroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-9489","authenticated-orcid":false,"given":"Armando","family":"Sardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6151-5660","authenticated-orcid":false,"given":"Vadim","family":"Gushchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejso.2025.110536_bib2","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/02656736.2015.1114153","article-title":"Is CEM43 still a relevant thermal dose parameter for hyperthermia treatment monitoring?","volume":"32","author":"Van Rhoon","year":"2016","journal-title":"Int J Hyperther"},{"issue":"27","key":"10.1016\/j.ejso.2025.110536_bib5","doi-asserted-by":"crossref","first-page":"44593","DOI":"10.18632\/oncotarget.17861","article-title":"The effect of thermal dose on hyperthermia-mediated inhibition of DNA repair through homologous recombination","volume":"8","author":"Van Den Tempel","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ejso.2025.110536_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/0265673031000119006","article-title":"Basic principles of thermal dosimetry and thermal thresholds for tissue damage from hyperthermia","volume":"19","author":"Dewhirst","year":"2003","journal-title":"Int J Hyperther"},{"issue":"4","key":"10.1016\/j.ejso.2025.110536_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3109\/02656736.2013.786140","article-title":"Comparative analysis of mathematical models of cell death and thermal damage processes","volume":"29","author":"Pearce","year":"2013","journal-title":"Int J Hyperther"},{"issue":"13","key":"10.1016\/j.ejso.2025.110536_bib1","doi-asserted-by":"crossref","first-page":"9098","DOI":"10.1245\/s10434-021-10193-w","article-title":"HIPEC methodology and regimens: the need for an expert consensus","volume":"28","author":"Bhatt","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"19","key":"10.1016\/j.ejso.2025.110536_bib6","doi-asserted-by":"crossref","first-page":"4795","DOI":"10.3390\/cancers14194795","article-title":"Avoiding pitfalls in thermal dose effect relationship studies: a review and guide forward","volume":"14","author":"Carrapi\u00e7o-Seabra","year":"2022","journal-title":"Cancers"},{"issue":"8","key":"10.1016\/j.ejso.2025.110536_bib7","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1080\/15384047.2020.1775444","article-title":"A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function","volume":"21","author":"Ye","year":"2020","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ejso.2025.110536_bib8","doi-asserted-by":"crossref","DOI":"10.5705\/ss.202021.0268","article-title":"Bootstrap adjustment to minimum p-Value method for predictive classification","author":"Li","year":"2023","journal-title":"Stat Sin"},{"issue":"3","key":"10.1016\/j.ejso.2025.110536_bib34","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/bjc.2013.753","article-title":"Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer","volume":"110","author":"Jonker","year":"2014","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ejso.2025.110536_bib35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10549-018-4785-z","article-title":"Exploration of tumour-infiltrating lymphocytes as a predictive biomarker for adjuvant endocrine therapy in early breast cancer","volume":"171","author":"Blok","year":"2018","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.ejso.2025.110536_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1097\/DCR.0000000000001003","volume":"61","author":"Paul","year":"2018","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejso.2025.110536_bib10","series-title":"Peritoneal carcinomatosis: principles of management. Vol 82. Cancer treatment and research","first-page":"359","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","author":"Jacquet","year":"1996"},{"issue":"6","key":"10.1016\/j.ejso.2025.110536_bib11","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.hoc.2012.08.010","article-title":"Neoplasms of the appendix","volume":"26","author":"Shankar","year":"2012","journal-title":"Hematol Oncol Clin N Am"},{"issue":"2","key":"10.1016\/j.ejso.2025.110536_bib12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/SLA.0b013e3181b13ca2","article-title":"The clavien-dindo classification of surgical complications: five-year experience","volume":"250","author":"Clavien","year":"2009","journal-title":"Ann Surg"},{"issue":"5505","key":"10.1016\/j.ejso.2025.110536_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/255228a0","article-title":"Differential heat response of normal and transformed human cells in tissue culture","volume":"255","author":"Kase","year":"1975","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ejso.2025.110536_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00908-0","article-title":"Development of accurate temperature regulation culture system with metallic culture vessel demonstrates different thermal cytotoxicity in cancer and normal cells","volume":"11","author":"Imashiro","year":"2021","journal-title":"Sci Rep"},{"issue":"4","key":"10.1016\/j.ejso.2025.110536_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1080\/02656730310001637325","article-title":"Thermal enhancement of oxaliplatin-induced inhibition of cell proliferation and cell cycle progression in human carcinoma cell lines","volume":"20","author":"Atallah","year":"2004","journal-title":"Int J Hyperther"},{"issue":"1","key":"10.1016\/j.ejso.2025.110536_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/02656730701769841","article-title":"Cellular responses to hyperthermia (40\u201346 \u00b0 C): cell killing and molecular events","volume":"24","author":"Roti","year":"2008","journal-title":"Int J Hyperther"},{"issue":"8","key":"10.1016\/j.ejso.2025.110536_bib17","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.3390\/cells9081775","article-title":"The temperature-dependent effectiveness of platinum-based drugs Mitomycin-C and 5-FU during hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer cell lines","volume":"9","author":"Helderman","year":"2020","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.ejso.2025.110536_bib18","doi-asserted-by":"crossref","first-page":"3516","DOI":"10.3390\/cancers12123516","article-title":"A four-inflow construction to ensure thermal stability and uniformity during hyperthermic intraperitoneal chemotherapy (HIPEC) in rats","volume":"12","author":"L\u00f6ke","year":"2020","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.ejso.2025.110536_bib19","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1080\/02656736.2020.1852324","article-title":"Demonstration of treatment planning software for hyperthermic intraperitoneal chemotherapy in a rat model","volume":"38","author":"L\u00f6ke","year":"2021","journal-title":"Int J Hyperther"},{"issue":"8","key":"10.1016\/j.ejso.2025.110536_bib20","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jso.23776","article-title":"Higher flow rates improve heating during hyperthermic intraperitoneal chemoperfusion: higher flow rates improve HIPEC heating","volume":"110","author":"Furman","year":"2014","journal-title":"J Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2025.110536_bib21","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1097\/SLA.0b013e3182582b38","article-title":"High pressure enhances the effect of hyperthermia in intraperitoneal chemotherapy with oxaliplatin: an experimental study","volume":"256","author":"Facy","year":"2012","journal-title":"Ann Surg"},{"issue":"1","key":"10.1016\/j.ejso.2025.110536_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10717544.2020.1862364","article-title":"Simulating drug penetration during hyperthermic intraperitoneal chemotherapy","volume":"28","author":"L\u00f6ke","year":"2021","journal-title":"Drug Deliv"},{"issue":"6","key":"10.1016\/j.ejso.2025.110536_bib23","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1590\/0100-69912016006014","article-title":"Exploring flow rate selection in HIPEC procedures","volume":"43","author":"Batista","year":"2016","journal-title":"Rev Col\u00e9gio Bras Cir"},{"issue":"10","key":"10.1016\/j.ejso.2025.110536_bib24","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1158\/0008-5472.CAN-15-2908","article-title":"Hyperthermia synergizes with chemotherapy by inhibiting PARP1-Dependent DNA replication arrest","volume":"76","author":"Schaaf","year":"2016","journal-title":"Cancer Res"},{"issue":"4","key":"10.1016\/j.ejso.2025.110536_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1080\/02656730210123534","article-title":"Thermal enhancement of melphalan and oxaliplatin cytotoxicity in vitro","volume":"18","author":"Urano","year":"2002","journal-title":"Int J Hyperther"},{"issue":"2","key":"10.1016\/j.ejso.2025.110536_bib26","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/026567399285765","article-title":"Invited review: for the clinical application of thermochemotherapy given at mild temperatures","volume":"15","author":"Urano","year":"1999","journal-title":"Int J Hyperther"},{"issue":"1","key":"10.1016\/j.ejso.2025.110536_bib31","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00348209","article-title":"Continuous hyperthermic peritoneal perfusion for the prevention of peritoneal recurrence of gastric cancer: randomized controlled study","volume":"18","author":"Fujimura","year":"1994","journal-title":"World J Surg"},{"issue":"S3","key":"10.1016\/j.ejso.2025.110536_bib27","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1245\/s10434-015-4853-0","article-title":"A temperature of 40 \u00b0C appears to be a critical threshold for potentiating cytotoxic chemotherapy in vitro and in peritoneal carcinomatosis patients undergoing HIPEC","volume":"22","author":"Schaaf","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2025.110536_bib28","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1634\/theoncologist.10-2-112","article-title":"Update on chemotherapeutic agents utilized for perioperative intraperitoneal chemotherapy","volume":"10","author":"Sugarbaker","year":"2005","journal-title":"Oncologist"},{"issue":"1","key":"10.1016\/j.ejso.2025.110536_bib29","first-page":"45","article-title":"Chemotherapy for intraperitoneal use: a review of hyperthermic intraperitoneal chemotherapy and early post-operative intraperitoneal chemotherapy","volume":"7","author":"Goodman","year":"2016","journal-title":"J Gastrointest Oncol"},{"issue":"13","key":"10.1016\/j.ejso.2025.110536_bib30","doi-asserted-by":"crossref","first-page":"4950","DOI":"10.1245\/s10434-020-08790-2","article-title":"Personalized identification of optimal HIPEC perfusion protocol in patient-derived tumor organoid platform","volume":"27","author":"Forsythe","year":"2020","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798325009643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T07:57:12Z","timestamp":1767945432000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798325009643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S0748798325009643"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110536","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Controlling perfusion temperature relates to better outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2025.110536","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110536"}}